DAWES KAREN A 5
5 · Vaccitech plc · Filed Feb 10, 2023
Insider Transaction Report
Form 5
Vaccitech plcVACC
DAWES KAREN A
Director
Transactions
- Award
Share Option (Right to Buy)
2022-06-15+18,604→ 18,604 totalExercise: $4.27Exp: 2032-06-15→ Ordinary Shares (18,604 underlying)
Footnotes (2)
- [F1]One-third of the shares underlying this option shall vest and become exercisable on June 15, 2023, with the remainder vesting in 24 equal monthly installments thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.